<?xml version="1.0" encoding="UTF-8"?>
<resource xmlns="http://datacite.org/schema/kernel-4" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://datacite.org/schema/kernel-4 http://schema.datacite.org/meta/kernel-4.1/metadata.xsd">
  <identifier identifierType="DOI">10.18453/rosdok_id00004044</identifier>
  <creators>
    <creator>
      <creatorName nameType="Personal">Kamaleddine, Imad</creatorName>
      <givenName>Imad</givenName>
      <familyName>Kamaleddine</familyName>
      <nameIdentifier nameIdentifierScheme="GND" schemeURI="http://d-nb.info/gnd/">http://d-nb.info/gnd/1247129918</nameIdentifier>
    </creator>
  </creators>
  <titles>
    <title>Unterdrucktherapie als neue Therapieoption bei der Behandlung von transsphinktären Analfisteln</title>
  </titles>
  <publisher>Universität Rostock</publisher>
  <publicationYear>2021</publicationYear>
  <resourceType resourceTypeGeneral="Text" />
  <subjects>
    <subject xml:lang="en" schemeURI="http://dewey.info/" subjectScheme="dewey">610 Medical sciences Medicine</subject>
  </subjects>
  <dates>
    <date dateType="Created">2021</date>
  </dates>
  <language>de</language>
  <alternateIdentifiers>
    <alternateIdentifier alternateIdentifierType="PURL">http://purl.uni-rostock.de/rosdok/id00004044</alternateIdentifier>
    <alternateIdentifier alternateIdentifierType="URN">urn:nbn:de:gbv:28-rosdok_id00004044-7</alternateIdentifier>
  </alternateIdentifiers>
  <descriptions>
    <description descriptionType="Abstract">Transsphincteric Anal fistula remains a challenging issue for both surgeons &amp; patients. Aggressive treatments are associated with high risk of incontinence whereas minimally invasive methods might lead to more recurrences. 4 Pigs (Sus Scrofa Domesticus) underwent a surgical creation of 4 iatrogenic transsphincteric anal fistulas by each animal in the supine positions 2, 5, 8 and 11 o’clock. 6/12 Fistulas were treated by Vacuum therapy. All treated fistulas healed very well and showed no adverse reactions. This new therapy is feasible and safe.</description>
  </descriptions>
</resource>
